New insights on depression in multiple sclerosis – a literature review
Nowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on th...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-12-01
|
Series: | Romanian Journal of Neurology |
Subjects: | |
Online Access: | https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdf |
id |
doaj-5348ccf86215477fa6efac89f725ed30 |
---|---|
record_format |
Article |
spelling |
doaj-5348ccf86215477fa6efac89f725ed302021-08-13T10:32:52ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942020-12-0119423724310.37897/RJN.2020.4.4New insights on depression in multiple sclerosis – a literature reviewThomas Gabriel Schreiner0Bogdan Emilian Ignat1Neurology Department, Clinical Rehabilitation Hospital, Iasi, Romania; “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, Romania; “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaNeurology Department, Clinical Rehabilitation Hospital, Iasi, Romania; “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, RomaniaNowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on the relationship between depression and MS, depression being the most important factor influencing the MS patient’s quality of life. In this regard, the article aims to present a selection of the most important scientific data published during the last 5 years on this topic. Structured in two parts, the initial issue discussed is the etiopathogenesis of depression in MS, with focus on the presentation of theories on the causes of depressive symptoms in demyelinating disease, as well as the intricate relationship between the two clinical entities. Subsequently, the article focuses on capturing the latest developments in currently available pharmacological and non-pharmacological therapeutic means and future prospects for treatment.https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdfmultiple sclerosisdepressionethiopathogenytreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thomas Gabriel Schreiner Bogdan Emilian Ignat |
spellingShingle |
Thomas Gabriel Schreiner Bogdan Emilian Ignat New insights on depression in multiple sclerosis – a literature review Romanian Journal of Neurology multiple sclerosis depression ethiopathogeny treatment |
author_facet |
Thomas Gabriel Schreiner Bogdan Emilian Ignat |
author_sort |
Thomas Gabriel Schreiner |
title |
New insights on depression in multiple sclerosis – a literature review |
title_short |
New insights on depression in multiple sclerosis – a literature review |
title_full |
New insights on depression in multiple sclerosis – a literature review |
title_fullStr |
New insights on depression in multiple sclerosis – a literature review |
title_full_unstemmed |
New insights on depression in multiple sclerosis – a literature review |
title_sort |
new insights on depression in multiple sclerosis – a literature review |
publisher |
Amaltea Medical Publishing House |
series |
Romanian Journal of Neurology |
issn |
1843-8148 2069-6094 |
publishDate |
2020-12-01 |
description |
Nowadays, the success of multiple sclerosis therapy does not only mean the absence of relapses or the existence of a stationary clinical status under disease-modifying therapy, but the maintenance of a high quality of life index. Thus, in recent years, the attention of neurologists has focused on the relationship between depression and MS, depression being the most important factor influencing the MS patient’s quality of life. In this regard, the article aims to present a selection of the most important scientific data published during the last 5 years on this topic. Structured in two parts, the initial issue discussed is the etiopathogenesis of depression in MS, with focus on the presentation of theories on the causes of depressive symptoms in demyelinating disease, as well as the intricate relationship between the two clinical entities. Subsequently, the article focuses on capturing the latest developments in currently available pharmacological and non-pharmacological therapeutic means and future prospects for treatment. |
topic |
multiple sclerosis depression ethiopathogeny treatment |
url |
https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-04.pdf |
work_keys_str_mv |
AT thomasgabrielschreiner newinsightsondepressioninmultiplesclerosisaliteraturereview AT bogdanemilianignat newinsightsondepressioninmultiplesclerosisaliteraturereview |
_version_ |
1721208420900536320 |